Pitney Bowes Inc (PBI) Falls 3.62% for January 07

Equities Staff  |

One of the S&P 500’s big losers for Thursday January 07 was Pitney Bowes Inc (PBI). The company’s stock fell 3.62% to $19.44 on volume of 1.7 million shares.

The stock opened the day at 19.78 and traded between a low of $19.33 and a high of $19.96. The stock finished the day down $0.73 per share. Pitney Bowes Inc has an average daily volume of 1.51 million and a total float of 197.05 million shares. The 50-day SMA for Pitney Bowes Inc is $20.61 and its 200-day SMA is $21.00. The high for the stock over the last 52 weeks is $24.54 and the low is $18.59.

Pitney Bowes Inc is a technology company that offers products and solutions that enable commerce in the areas of customer information management, location intelligence, customer engagement, shipping and mailing, and e-commerce.

Pitney Bowes Inc is centered in Stamford, CT, and has 15,200 employees. Today’s trading day leaves the company with a market cap of $3.83 billion. The company has a P/S ratio of n/a, P/B ratio of 27, and a 2116.3.

For a complete fundamental analysis analysis of Pitney Bowes Inc, check out Equities.com’s Stock Valuation Analysis report for PBI. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Invictus MD Strategies Corp

Invictus MD Strategies Corp is focused on two main verticals within the Canadian cannabis sector under the Access to Cannabis for Medical Purposes Regulations having investment in Acreage Pharms Ltd.,…